Page last updated: 2024-08-23

lithium and olanzapine

lithium has been researched along with olanzapine in 69 studies

Research

Studies (69)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (5.80)18.2507
2000's41 (59.42)29.6817
2010's15 (21.74)24.3611
2020's9 (13.04)2.80

Authors

AuthorsStudies
Tohen, M; Zarate, CA1
DeGolia, SG; Dunai, M; Ketter, TA; Strong, CM; Tate, DL; Winsberg, ME1
Grundy, S; Tohen, M1
Berk, M; Brook, S; Ichim, L1
Ghaemi, SN; Guille, C; Sachs, GS1
Nemeroff, CB1
Ghaemi, SN1
Gundlapalli, SP; Iqbal, MM; Passman, TE; Ryals, T; Ryan, WG1
Gibson, PJ; Greaney, MG; Grundy, SL; Namjoshi, MA; Sanger, TM; Tohen, MF1
Grace, JJ; Narendran, R; Pato, MT; Pristach, CA; Valenti, AM; Young, CM1
Flockhart, DA; Rosebraugh, CJ; Woosley, RL; Yasuda, SU1
Yatham, LN1
Meyer, JM1
Fossion, P; Paquet, V; Pelc, I; Servais, L; Strul, J1
Fernandez-Corres, B; Gonzalez-Pinto, A; Gutierrez, M; Lalaguna, B; Micó, JA; Pérez-Heredia, JL; Tohen, M1
Berry, N; Gupta, SK; Pradhan, S; Sagar, R1
Schatzberg, AF2
Manning, JS1
Grof, P1
Iwazaki, H1
Basile, VS; Kennedy, SH; Mancini, DA; McIntyre, RS; Srinivasan, J1
Baker, JD; Hirschfeld, RM; Sommerville, KW; Tracy, K; Wozniak, P1
Dittmann, S; Grunze, H1
Baker, RW; Bowden, CL; Calabrese, JR; Chengappa, KN; Evans, AR; Feldman, PD; Ghaemi, SN; Kupfer, DJ; Risser, RC; Sachs, GS; Suppes, T; Tohen, M; Zarate, CA1
Bagnall, AM; Bridle, C; Darba, J; Duffy, S; Palmer, S; Riemsma, R; Sculpher, M1
Kass, E; Klein, RM; Lewis, FT1
Ghaemi, SN; Hsu, DJ; Pardo, TB1
Oral, ET; Vahip, S1
Baldessarini, RJ; Calabrese, JR; Colom, F; Hennen, J; Martínez-Arán, A; Sánchez-Moreno, J; Tohen, M; Vieta, E; Yatham, LN1
Kennedy, SH; Konarski, JZ; Mancini, DA; McCann, S; McIntyre, RS; Srinivasan, J1
Keck, PE1
Baker, RW; Bowden, CL; Calabrese, JR; Cassano, GB; Crane, H; Dell'Osso, L; Dossenbach, MR; Evans, AR; Greil, W; Grunze, H; Koukopoulos, A; Licht, RW; Oerlinghausen, BM; Risser, R; Sachs, GS; Tohen, M; Yatham, LN1
Abay, E; Erdogan, E; Tuglu, C1
Danielyan, A; Kowatch, RA1
Adams, DH; Houston, JP; Ketter, TA; Meyers, AL; Risser, RC; Tohen, M; Williamson, DJ1
Arora, M; Praharaj, SK1
Gourion, D; Mouaffak, F1
Ebinger, M; Knetsch, I; Rosenhagen, MC; Schmidt, U; Weber, F; Winkelmann, J1
Ahl, J; Baldessarini, RJ; Houston, JP; Kaiser, CJ; Meyers, AL; Tohen, M1
Barbieri, M; Beynon, S; Bravo Vergel, Y; Duffy, S; Dunn, G; Geddes, J; Gilbody, S; Palmer, S; Soares-Weiser, K; Woolacott, N1
Hammonds, MD; Shim, SS1
Colom, F; Girardi, P; Kotzalidis, GD; Mazzarini, L; Pacchiarotti, I; Sanchez-Moreno, J; Vieta, E1
Deberdt, W; Greil, W; Ketter, T; Licht, RW; Lipkovich, IA; Severus, WE; Tohen, M; Young, AH1
Glue, P; Herbison, P; Tarr, GP1
Fisar, Z; Hroudová, J; Raboch, J1
Degenhardt, EK; Gatz, JL; Jacob, J; Tohen, M1
Higuchi, T; Kanba, S; Katagiri, H; Takahashi, M; Takita, Y; Tohen, M1
Eppendorfer, S; Grunze, H; Henneges, C; Hundemer, HP; Kraemer, S; Minarzyk, A; Wilhelm, S1
Bahk, WM; Kim, MD; Kwon, YJ; Lee, HB; Lee, JG; Woo, YS; Yoon, BH1
Fusté, M; Gill, G; Haro, JM; Meléndez-Pérez, I; Pinacho, R; Ramos, B; Saia, G; Villalta-Gil, V1
Baruch, P; Beaulieu, S; Bond, DJ; da Cunha, A; Daigneault, A; Dias, R; Kapczinski, F; Kauer-Sant'Anna, M; Kunz, M; Lafer, B; Lam, RW; Milev, R; Parikh, SV; Qian, H; Quevedo, J; Schaffer, A; Sharma, V; Silverstone, PH; Walji, N; Wong, H; Yatham, LN; Young, LT1
Berk, M; Conus, P; Cotton, SM; Hallam, K; Hasty, MK; Kader, L; Lambert, M; Macneil, C; McGorry, PD; Murphy, BP1
Karanti, A; Kardell, M; Landén, M; Lundberg, U1
Abbasi, Y; Foulser, P; Mathilakath, A; Nilforooshan, R1
Nurchi, AM; Pinna, AP; Podda, F; Ripoli, C; Tronci, MG; Zanni, R1
Carvalho, AF; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E; Young, AH1
Aguiar-Ribeiro, EM; Assmann, CE; Azzolin, VF; Barbisan, F; da Cruz Jung, IE; da Cruz, IBM; do Prado-Lima, PAS; Duarte, MMMF; Fernandes, MS; Riffel, RT; Teixeira, CF1
Kazah, N; Peña-Salazar, C1
Bauer, M; Bohlken, J; Kostev, K; Riedel-Heller, S1
Ferreira, A; Gouverneur, A; Morival, C; Pageot, C; Pariente, A; Tournier, M1
Bakker, IM; Kamphuis, J; Schoevers, RA; Smith-Apeldoorn, SY; Touw, DJ; Veraart, JKE; Visser, BAE1
Baldessarini, RJ; Gaudiot, CES; Nestsiarovich, A; Tohen, M; Vieta, E; Zhu, Y1
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K1
Berk, M; Bortolasci, CC; Dean, OM; Gray, L; Kidnapillai, S; Kim, JH; Liu, ZSJ; McGee, SL; Panizzutti, B; Richardson, MF; Spolding, B; Swinton, C; Truong, TTT; Walder, K1
Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J1
Arslan, MA; Bilgici, B; Gümrükçüoğlu, Tİ; Karaustaoğlu, A; Tunçel, ÖK1

Reviews

28 review(s) available for lithium and olanzapine

ArticleYear
Antipsychotic agents and bipolar disorder.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 1

    Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Lithium; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Treatment Outcome

1998
Management of acute mania.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 5

    Topics: Acute Disease; Algorithms; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Humans; Lithium; Olanzapine; Pirenzepine; Research Design; Risk Factors; Treatment Outcome; Treatment Refusal; Valproic Acid

1999
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
    The Journal of clinical psychiatry, 2000, Volume: 61 Supp 13

    Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroconvulsive Therapy; Electromagnetic Phenomena; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Topiramate; Treatment Outcome; Triazines; Valproic Acid

2000
New treatments for bipolar disorder: the role of atypical neuroleptic agents.
    The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 14

    Topics: Acute Disease; Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Humans; Lithium; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid

2000
Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants.
    Southern medical journal, 2001, Volume: 94, Issue:3

    Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Antimanic Agents; Benzodiazepines; Breast Feeding; Carbamazepine; Cyclohexanecarboxylic Acids; Female; Fetus; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Infant, Newborn; Lithium; Mood Disorders; Olanzapine; Pirenzepine; Placenta; Pregnancy; Risk Factors; Valproic Acid

2001
The role of novel antipsychotics in bipolar disorders.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 3

    Topics: Acute Disease; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Haloperidol; Humans; Lithium; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Risperidone

2002
Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.
    Pharmacotherapy, 2003, Volume: 23, Issue:2

    Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lithium; Male; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine

2003
New approaches to managing psychotic depression.
    The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 1

    Topics: Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Mifepristone; Olanzapine; Pirenzepine; Receptors, Glucocorticoid; Treatment Outcome

2003
Difficult-to-treat depressions: a primary care perspective.
    The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 1

    Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Medical Records; Olanzapine; Pirenzepine; Primary Health Care; Psychotherapy

2003
Selecting effective long-term treatment for bipolar patients: monotherapy and combinations.
    The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 5

    Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Long-Term Care; Olanzapine; Pirenzepine; Treatment Outcome; Triazines

2003
[Manic phase (manic episode)].
    Ryoikibetsu shokogun shirizu, 2003, Issue:38

    Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Electroconvulsive Therapy; Humans; Lithium; Olanzapine; Pirenzepine; Psychotherapy; Reference Standards; Valproic Acid

2003
The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Tolerance; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Severity of Illness Index; Titrimetry; Treatment Outcome; Valproic Acid

2003
[Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Acute Disease; Algorithms; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Isotopes; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Triazines; Valproic Acid

2003
A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Health technology assessment (Winchester, England), 2004, Volume: 8, Issue:19

    Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Valproic Acid

2004
An overview of primary care assessment and management of bipolar disorder.
    The Journal of the American Osteopathic Association, 2004, Volume: 104, Issue:6 Suppl 6

    Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic Errors; Humans; Lamotrigine; Lithium; Olanzapine; Primary Health Care; Triazines; Valproic Acid

2004
Strategies for preventing the recurrence of bipolar disorder.
    The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 10

    Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Patient Education as Topic; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Triazines; Valproic Acid

2004
Bipolar depression: an overview.
    IDrugs : the investigational drugs journal, 2004, Volume: 7, Issue:9

    Topics: Acute Disease; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Chemoprevention; Contraindications; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Triazines; Valproic Acid

2004
Employing pharmacologic treatment of bipolar disorder to greatest effect.
    The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 15

    Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Receptors, GABA; Receptors, Glutamate; Treatment Outcome; Triazines; Valproic Acid

2004
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
    The Journal of clinical psychiatry, 2005, Volume: 66 Suppl 3

    Topics: Acute Disease; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Double-Blind Method; Humans; Lithium; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome

2005
Management options for bipolar disorder in children and adolescents.
    Paediatric drugs, 2005, Volume: 7, Issue:5

    Topics: Adolescent; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Clozapine; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid

2005
A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Health technology assessment (Winchester, England), 2007, Volume: 11, Issue:39

    Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cognitive Behavioral Therapy; Cost-Benefit Analysis; Databases, Bibliographic; Female; Humans; Lamotrigine; Lithium; Male; Models, Economic; Olanzapine; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic; Secondary Prevention; Triazines; Valproic Acid

2007
Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis.
    Journal of affective disorders, 2011, Volume: 134, Issue:1-3

    Topics: Affect; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Humans; Lithium; Lithium Carbonate; Lithium Compounds; Mood Disorders; Olanzapine; Randomized Controlled Trials as Topic; Valproic Acid

2011
The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study.
    Clinical drug investigation, 2013, Volume: 33, Issue:10

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Substitution; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Thiazoles; Treatment Outcome; Valproic Acid; Young Adult

2013
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
    Acta psychiatrica Scandinavica, 2018, Volume: 138, Issue:3

    Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Thiazoles; Valproic Acid

2018
Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review.
    The international journal of neuropsychopharmacology, 2021, 10-23, Volume: 24, Issue:10

    Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Depression; Drug Interactions; Female; Haloperidol; Humans; Ketamine; Lithium; Male; Olanzapine; Psychotropic Drugs; Risperidone; Schizophrenia; Treatment Outcome

2021
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2022, Volume: 54

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone

2022
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
    Molecular psychiatry, 2022, Volume: 27, Issue:2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid

2022
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
    Psychopharmacology, 2022, Volume: 239, Issue:10

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid

2022

Trials

16 trial(s) available for lithium and olanzapine

ArticleYear
Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.
    International clinical psychopharmacology, 1999, Volume: 14, Issue:6

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Prospective Studies; Psychiatric Status Rating Scales

1999
A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:9

    Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Body Weight; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid

2000
Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:4

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep; Treatment Outcome; Weight Gain

2001
Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:7

    Topics: Adult; Affective Disorders, Psychotic; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Brief Psychiatric Rating Scale; Cohort Studies; Depressive Disorder; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Treatment Outcome; Valproic Acid

2001
Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.
    Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:5

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Chemotherapy, Adjuvant; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Time Factors; Valproic Acid

2002
Antipsychotic-induced weight gain: bipolar disorder and leptin.
    Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Female; Humans; Leptin; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Risperidone; Valproic Acid; Weight Gain

2003
The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Tolerance; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Severity of Illness Index; Titrimetry; Treatment Outcome; Valproic Acid

2003
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
    The British journal of psychiatry : the journal of mental science, 2004, Volume: 184

    Topics: Adult; Aged; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Olanzapine; Recurrence; Time Factors; Valproic Acid

2004
Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Longitudinal Studies; Male; Meta-Analysis as Topic; Olanzapine; Proportional Hazards Models; Psychiatric Status Rating Scales; Survival Analysis; Treatment Outcome

2004
The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique, 2004,Fall, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Weight; Chemotherapy, Adjuvant; Depression; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Time Factors; Valproic Acid

2004
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    The American journal of psychiatry, 2005, Volume: 162, Issue:7

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Longitudinal Studies; Male; Olanzapine; Psychiatric Status Rating Scales; Secondary Prevention; Treatment Outcome

2005
Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:1

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Prognosis; Psychiatric Status Rating Scales; Secondary Prevention; Time Factors; Treatment Outcome

2006
Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:8

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Placebos; Principal Component Analysis; Psychiatric Status Rating Scales; Risk Factors; Suicide; Treatment Outcome; Valproic Acid

2006
Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Current medical research and opinion, 2012, Volume: 28, Issue:5

    Topics: Adult; Affect; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Japan; Lithium; Male; Middle Aged; Olanzapine; Prolactin; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Valproic Acid

2012
Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
    Molecular psychiatry, 2016, Volume: 21, Issue:8

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Combined Modality Therapy; Double-Blind Method; Female; Humans; Lithium; Male; Olanzapine; Risperidone; Time Factors; Weight Gain

2016
Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial.
    European psychiatry : the journal of the Association of European Psychiatrists, 2015, Volume: 30, Issue:8

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Humans; Lithium; Male; Olanzapine; Psychotic Disorders; Treatment Outcome

2015

Other Studies

26 other study(ies) available for lithium and olanzapine

ArticleYear
Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:2

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Thyroxine; Valproic Acid

1998
Olanzapine-induced rhabdomyolysis.
    The Annals of pharmacotherapy, 2001, Volume: 35, Issue:9

    Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Diagnosis, Differential; Electrocardiography; Humans; Lithium; Male; Olanzapine; Pirenzepine; Rhabdomyolysis

2001
A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:5

    Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Fasting; Female; Glucose Tolerance Test; Hospitalization; Humans; Hyperlipidemias; Lipid Metabolism; Lipids; Lithium; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Pirenzepine; Retrospective Studies; Risperidone; Schizophrenia; Valproic Acid

2002
Sleep-related eating disorder induced by olanzapine.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:7

    Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Feeding and Eating Disorders; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Sleep Wake Disorders; Somnambulism

2002
[Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Dopamine Antagonists; Drug Therapy, Combination; Haloperidol; Humans; Isotopes; Lithium; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Time Factors; Valproic Acid

2003
[Long-term therapy with intuition].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Drug Therapy, Combination; Hospitalization; Humans; Isotopes; Lithium; Olanzapine; Patient Readmission; Pirenzepine; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Valproic Acid

2003
Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.
    Journal of Korean medical science, 2005, Volume: 20, Issue:4

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Delirium; Drug Therapy, Combination; Female; Humans; Lithium; Middle Aged; Olanzapine

2005
Stevens-Johnson syndrome (SJS) leading to resolution of mania.
    The Australian and New Zealand journal of psychiatry, 2006, Volume: 40, Issue:2

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Male; Olanzapine; Psychotic Disorders; Severity of Illness Index; Stevens-Johnson Syndrome; Surveys and Questionnaires; Treatment Outcome

2006
[Humor in bipolar disorder].
    L'Encephale, 2005, Volume: 31 Pt 2

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Lithium; Male; Olanzapine; Wit and Humor as Topic

2005
Olanzapine-induced oculogyric crisis.
    Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:4

    Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Female; Humans; Lithium; Ocular Motility Disorders; Olanzapine

2006
Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus.
    Basic & clinical pharmacology & toxicology, 2009, Volume: 105, Issue:2

    Topics: Animals; Benzodiazepines; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Dentate Gyrus; Hippocampus; Lithium; Lithium Carbonate; Male; Olanzapine; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley

2009
Treatment-resistant bipolar depression: towards a new definition.
    Acta psychiatrica Scandinavica, 2009, Volume: 120, Issue:6

    Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Resistance; Evidence-Based Practice; Fluoxetine; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic

2009
In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005.
    European psychiatry : the journal of the Association of European Psychiatrists, 2010, Volume: 25, Issue:8

    Topics: Antimanic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Female; Humans; Lithium; Logistic Models; Male; Olanzapine; Proportional Hazards Models; Recurrence; Risk Factors; Severity of Illness Index; Treatment Outcome

2010
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Neuro endocrinology letters, 2010, Volume: 31, Issue:5

    Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride

2010
Predictors of relapse or recurrence in bipolar I disorder.
    Journal of affective disorders, 2012, Volume: 136, Issue:3

    Topics: Adolescent; Adult; Aged; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Olanzapine; Prognosis; Recurrence; Valproic Acid

2012
Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study.
    BMC psychiatry, 2013, Jul-17, Volume: 13

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Germany; Humans; Lithium; Male; Medication Adherence; Middle Aged; Olanzapine; Prospective Studies; Recurrence; Treatment Outcome; Young Adult

2013
Phosphorylation of transcription factor specificity protein 4 is increased in peripheral blood mononuclear cells of first-episode psychosis.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Animals; Antipsychotic Agents; Benzodiazepines; Cells, Cultured; Cross-Sectional Studies; Female; Humans; Lithium; Male; Models, Biological; Neurons; Olanzapine; Phosphorylation; Pilot Projects; Psychotic Disorders; Rats; Serine; Sp4 Transcription Factor; Valproic Acid; Young Adult

2015
Changes in mood stabilizer prescription patterns in bipolar disorder.
    Journal of affective disorders, 2016, Volume: 195

    Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Prescriptions; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Sweden; Valproic Acid

2016
Do not treat the numbers: lithium toxicity.
    BMJ case reports, 2017, Jun-02, Volume: 2017

    Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnosis, Differential; Humans; Lithium; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Secondary Prevention; Treatment Outcome

2017
Second-generation antipsychotic and diabetes mellitus in children and adolescents.
    La Pediatria medica e chirurgica : Medical and surgical pediatrics, 2017, Dec-13, Volume: 39, Issue:4

    Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Benzodiazepines; Blood Glucose; Clomipramine; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Insulin; Lithium; Male; Metformin; Olanzapine; Valproic Acid

2017
Lithium is able to minimize olanzapine oxidative-inflammatory induction on macrophage cells.
    PloS one, 2019, Volume: 14, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Cell Proliferation; Cytokines; Inflammation; Lithium; Macrophages; Mice; Olanzapine; Oxidative Stress; RAW 264.7 Cells

2019
Pica disorder as a symptom of depression in a patient with bipolar disorder and intellectual disability.
    Actas espanolas de psiquiatria, 2020, Volume: 48, Issue:1

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Depression; Female; Humans; Intellectual Disability; Lithium; Olanzapine; Pica; Topiramate

2020
Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram.
    Pharmacopsychiatry, 2021, Volume: 54, Issue:3

    Topics: Antipsychotic Agents; Bipolar Disorder; Citalopram; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Valproic Acid; Venlafaxine Hydrochloride

2021
A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis.
    British journal of clinical pharmacology, 2021, Volume: 87, Issue:10

    Topics: Antipsychotic Agents; Humans; Lithium; Male; Olanzapine; Pharmacovigilance; Somnambulism

2021
Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis.
    International journal of molecular sciences, 2022, Jun-28, Volume: 23, Issue:13

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Humans; Lithium; Olanzapine; Psychotropic Drugs; Quetiapine Fumarate; Ribosomes

2022
Increased levels of lipid and protein oxidation in rat prefrontal cortex after treatment by lithium, valproic acid, and olanzapine.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:10

    Topics: Advanced Oxidation Protein Products; Animals; Antipsychotic Agents; Benzodiazepines; Lithium; Male; Olanzapine; Prefrontal Cortex; Rats; Rats, Wistar; Valproic Acid

2023